Biology is becoming engineerable

we are investing in a future where bioengineering has industrial scale and speed, and today’s barely conceivable medicines are routine

Giving Back to Our Community: Volunteering at the Northwest Arkansas Food Bank

Our team recently volunteered at the Northwest Arkansas Food Bank, helping pack boxes that will provide thousands of nutritious meals to individuals and families across our region. In addition to supporting an impactful organization and its mission to fight food insecurity, it was also a meaningful opportunity for our team to collaborate and give back to the local community together. We’re grateful for the opportunity to support the Northwest Arkansas Food Bank and proud of our team for contributing to such important work. If you’d like to support the Northwest Arkansas Food Bank and help make a difference in our community, click on the link below to learn more or donate.
Donate

A New Path Forward for Patients Living with Epilepsy

As part of our new portfolio spotlight series focused on patient impact, we are highlighting stories that reflect the real-world potential of innovation across our portfolio companies. This spotlight features Neurona Therapeutics and its work advancing innovative cell therapy approaches for patients living with drug-resistant epilepsy, underscoring the meaningful impact emerging therapies may have on individuals and families affected by severe neurological conditions.
Optional Link

SymBiosis Messenger: Latest Updates & Portfolio Highlights

Check out the latest edition of the SymBiosis Messenger featuring portfolio updates, company news, industry insights, and highlights from across the SymBiosis ecosystem. Click below to read the full newsletter and stay connected with what’s happening at SymBiosis.
Ring 1
Ring 2
Ring 3
Ring 4
Ring 1
Ring 2
Ring 3
Ring 4

We partner with innovators

building groundbreaking companies with the following characteristics
treatment

Life-Threatening Disease With Hard Endpoint

agnostic across all life-threatening diseases with objective, well-established approvable endpoints

dna

Novel Therapeutic Platform In Any Modality

modality agnostic wherever cutting-edge discovery tools are being used to develop multiple compounds

clinical trials

Lead Reaching Human Proof-Of-Concept

lead candidate has human PoC or can achieve it within the horizon of our first investment

manufacturing

Designed for manufacturability

stage-appropriate evidence
of repeatable
and scalable
manufacturing

Tell us about your company

"*" indicates required fields

Accepted file types: pdf, ppt, Max. file size: 20 MB.